0 148

Cited 0 times in

Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial

DC Field Value Language
dc.contributor.author라선영-
dc.date.accessioned2023-06-02T00:51:43Z-
dc.date.available2023-06-02T00:51:43Z-
dc.date.issued2022-02-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194478-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherAmerican Society of Clinical Oncology-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleEfficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trial-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSun Young Rha-
dc.contributor.googleauthorToni K. Choueiri-
dc.contributor.googleauthorVsevolod B. Matveev-
dc.contributor.googleauthorAnna Alyasova-
dc.contributor.googleauthorSung-Hoo Hong-
dc.contributor.googleauthorTeresa Alonso Gordoa-
dc.contributor.googleauthorHoward Gurney-
dc.contributor.googleauthorGeorg A. Bjarnason-
dc.contributor.googleauthorTomas Buchler-
dc.contributor.googleauthorPaolo Pedrazzoli-
dc.contributor.googleauthorToshio Takagi-
dc.contributor.googleauthorSe Hoon Park-
dc.contributor.googleauthorJae-Lyun Lee-
dc.contributor.googleauthorRodolfo F. Perini-
dc.contributor.googleauthorCixin He-
dc.contributor.googleauthorJodi A. McKenzie-
dc.contributor.googleauthorMasatoshi Eto-
dc.identifier.doi10.1200/JCO.2022.40.6_suppl.338-
dc.contributor.localIdA01316-
dc.relation.journalcodeJ01331-
dc.identifier.eissn1527-7755-
dc.identifier.urlhttps://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.338-
dc.contributor.alternativeNameRha, Sun Young-
dc.contributor.affiliatedAuthor라선영-
dc.citation.volume40-
dc.citation.number6 Suppl-
dc.citation.startPageS338-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, Vol.40(6 Suppl) : S338, 2022-02-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.